Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Kuangli Bio-Tech Holdings Co., Ltd. (6431) Income Statement

Kuangli Bio-Tech Holdings Co., Ltd. Income Statement

Last quarter (Q2 2026), Kuangli Bio-Tech Holdings Co., Ltd.'s total revenue was NT$96.02M, an increase of 11.71% from the same quarter last year. In Q2, Kuangli Bio-Tech Holdings Co., Ltd.'s net income was NT$-48.77M. See Kuangli Bio-Tech Holdings Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 377.03MNT$ 381.30MNT$ 293.37MNT$ 342.16MNT$ 358.20M
NT$ 70.41MNT$ 68.32MNT$ 66.30MNT$ 68.69MNT$ 91.55M
NT$ 227.89MNT$ 206.40MNT$ 179.96MNT$ 157.46MNT$ 105.89M
Depreciation and AmortizationNT$ 86.88MNT$ 83.92MNT$ 60.65MNT$ 60.75MNT$ 39.91M
NT$ -92.46MNT$ -82.61MNT$ -48.85MNT$ -9.46MNT$ 107.52M
NT$ -157.48MNT$ -138.08MNT$ -113.65MNT$ -70.22MNT$ 64.69M
NT$ -35.56MNT$ -44.32MNT$ -10.02MNT$ -14.28MNT$ 60.14M
NT$ -193.04MNT$ -182.40MNT$ -123.67MNT$ -84.78MNT$ 60.74M
NT$ -193.04MNT$ -172.79MNT$ -104.16MNT$ -71.00MNT$ 55.95M
Per Share Metrics
Basic EPSNT$ -2.07NT$ -2.52NT$ -1.82NT$ -1.26NT$ 1.10
Diluted EPSNT$ -2.07NT$ -2.52NT$ -1.82NT$ -1.26NT$ 1.10
Weighted Average Shares Outstanding93.23M68.58M57.23M56.39M50.78M
Weighted Average Shares Outstanding (Diluted)93.23M68.58M57.24M56.39M50.78M

Currency in TWD

Kuangli Bio-Tech Holdings Co., Ltd. Earnings and Revenue History

-250M0250M500M-160 %-80 %0 %80 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin